Vista Pharmaceuticals has confirmed adherence to regulations concerning the dematerialization of shares.

The company, via its Registrar and Transfer Agent, certified that all securities received for conversion from physical to electronic form were duly processed.

This includes their verification, cancellation of physical certificates, and updating of records with the depository's name as the registered owner within the required timeframe.

This process ensures accurate shareholder data and that dematerialized shares are correctly listed on the stock exchange, maintaining operational integrity and investor trust in share transfers.